The study examines whether a peptide changes an injury-associated molecular pattern. Reversal of a pattern is not automatically reversal of the entire disease process. Primary report
What was measured
RNA sequencing was performed in a rat transient middle cerebral artery occlusion model. At 24 hours, the report identified 394 differentially expressed genes in the Semax-versus-saline comparison using its stated fold-change criterion. Inflammatory and neurotransmission-related gene categories showed patterns opposing some ischemia-reperfusion-associated changes. Primary report
Our appraisal: opposing direction is not complete normalization
A measurement can move toward a reference value without reaching it. It can also overshoot or change in one cell population while remaining abnormal in another. Therefore, a phrase such as “normalizes the brain” would be much broader than an expression-pattern comparison supports.
The number of differentially expressed genes is not a direct measure of therapeutic strength. It depends on measurement depth, variability, selection thresholds, and analysis choices. More changed genes need not mean greater benefit.
A complete review should recover the statistical criterion alongside the fold-change threshold, examine biological replicates, and identify whether validation used independent samples. It should also separate discovery analyses from confirmatory tests selected after the discovery results were known.
These molecular observations may guide hypotheses about injury responses. They do not alone establish improved cognition, disability, or survival, and they cannot validate a commercial formulation by name association.
Frequently asked questions
Was RNA sequencing used?
Yes, in an experimental rat model.
Did the study concern reperfusion after transient occlusion?
Yes. That distinguishes it from permanent-occlusion work.
Does an opposite-direction change prove full normalization?
No. Magnitude, reference values, and cell context matter.
Is the count of changed genes a benefit score?
No. It depends on analytical choices and biology.
Are discovery and independent validation identical?
No. Validation should test the finding beyond its discovery setting.
Were human disability outcomes measured here?
No. That is outside this experiment's reported scope.
What source was inspected?
The indexed primary abstract, with complete analysis review pending.